PUBLISHER: QYResearch | PRODUCT CODE: 1070859
PUBLISHER: QYResearch | PRODUCT CODE: 1070859
CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.
Market Analysis and Insights: Global CRM197 Market
The global CRM197 market size is projected to reach US$ 240.8 million by 2028, from US$ 172.2 million in 2021, at a CAGR of 5.3% during 2022-2028.
Pfizer Inc is one of the most important global manufacturers of CRM197, holds a share of over 85%. North America is the largest market, occupied for over 75%. In terms of type, research grade is the largest segment, with a share of over 85%. And in terms of application, pneumococcal conjugate vaccine segment holds a share of about 90%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRM197 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRM197 market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRM197 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRM197 market.
Global CRM197 Scope and Market Size
CRM197 market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global CRM197 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Segment by Application
By Company
By Region